Skip to main content

Advertisement

Log in

Deciphering the uranium target proteins in human dopaminergic SH-SY5Y cells

  • Inorganic Compounds
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Uranium (U) is the heaviest naturally occurring element ubiquitously present in the Earth’s crust. Human exposure to low levels of U is, therefore, unavoidable. Recently, several studies have clearly pointed out that the brain is a sensitive target for U, but the mechanisms leading to the observed neurological alterations are not fully known. To deepen our knowledge of the biochemical disturbances resulting from U(VI) toxicity in neuronal cells, two complementary strategies were set up to identify the proteins that selectively bind U(VI) in human dopaminergic SH-SY5Y cells. The first strategy relies on the selective capture of proteins capable of binding U(VI), using immobilized metal affinity chromatography, and starting from lysates of cells grown in a U(VI)-free medium. The second strategy is based on the separation of U-enriched protein fractions by size-exclusion chromatography, starting from lysates of U(VI)-exposed cells. High-resolution mass spectrometry helped us to highlight 269 common proteins identified as the urano-proteome. They were further analyzed to characterize their cellular localization and biological functions. Four canonical pathways, related to the protein ubiquitination system, gluconeogenesis, glycolysis, and the actin cytoskeleton proteins, were particularly emphasized due to their high content of U(VI)-bound proteins. A semi-quantification was performed to concentrate on the ten most abundant proteins, whose physico-chemical characteristics were studied in particular depth. The selective interaction of U(VI) with these proteins is an initial element of proof of the possible metabolic effects of U(VI) on neuronal cells at the molecular level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

Download references

Acknowledgements

We acknowledge the Transversal Toxicology Program run by the Direction de la Recherche Fondamentale (DRF) of the Commissariat à l’énergie atomique et aux énergies alternatives (CEA) and the financial support from this program. E.P. also thanks the CEA Enhanced Eurotalents program, co-funded by the European Commission through the Marie Sklodowska-Curie COFUND program under the 7th Framework Program for Research and Technological Development. This work was also partially funded by the CNRS Interdisciplinary Mission through the PEPS (Projet Exploratoire Premier Soutien) Faidora program (Faibles Doses, Risques, Alertes). We acknowledge the Li2D laboratory for its technical support.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Claude Vidaud or Véronique Malard.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vidaud, C., Robert, M., Paredes, E. et al. Deciphering the uranium target proteins in human dopaminergic SH-SY5Y cells. Arch Toxicol 93, 2141–2154 (2019). https://doi.org/10.1007/s00204-019-02497-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-019-02497-4

Keywords

Navigation